Open Access

[Retracted] Proteasome inhibitor sensitizes oral squamous cell carcinoma cells to TRAIL‑mediated apoptosis

  • Authors:
    • Sayaka Yoshiba
    • Masayasu Iwase
    • Sayaka Kurihara
    • Makiko Uchida
    • Yuji Kurihara
    • Hitoshi Watanabe
    • Satoru Shintani
  • View Affiliations

  • Published online on: March 6, 2023     https://doi.org/10.3892/or.2023.8519
  • Article Number: 82
  • Copyright : © Yoshiba et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that, in Fig. 4 on p. 650, the same β‑actin bands had apparently been used to show the experimental effects of the proteasome inhibitor MG‑132 on c‑FLIP in HSC‑2 cells in Fig. 4A, and the effects of MG‑132 on IAPs in HSC‑3 cells in Fig. 4B. In addition, for the fourth lane in the gel showing the effects of MG‑132 on c‑FLIP in HSC‑3 cells, this should have been labelled as ‘+MG‑132 / +TRAIL’ (not as ‘‑/‑’). Upon contacting the authors in relation to this matter, they could only admit that errors had been made in the preparation of the figure; moreover, they no longer had access to the original data owing to the time that has elapsed since the publication of the paper, and it would be impossible for them to now repeat this experiment. After having considered this matter and in conjunction with a request made by the authors, the Editor of Oncology Reports has decided that this paper should be retracted from the publication. Both the Editor and the authors apologize to the readership for any inconvenience caused. [Oncology Reports 25: 645‑652, 2011; DOI: 10.3892/or.2010.1127]

Related Articles

Journal Cover

May-2023
Volume 49 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yoshiba S, Iwase M, Kurihara S, Uchida M, Kurihara Y, Watanabe H and Shintani S: [Retracted] Proteasome inhibitor sensitizes oral squamous cell carcinoma cells to TRAIL‑mediated apoptosis. Oncol Rep 49: 82, 2023
APA
Yoshiba, S., Iwase, M., Kurihara, S., Uchida, M., Kurihara, Y., Watanabe, H., & Shintani, S. (2023). [Retracted] Proteasome inhibitor sensitizes oral squamous cell carcinoma cells to TRAIL‑mediated apoptosis. Oncology Reports, 49, 82. https://doi.org/10.3892/or.2023.8519
MLA
Yoshiba, S., Iwase, M., Kurihara, S., Uchida, M., Kurihara, Y., Watanabe, H., Shintani, S."[Retracted] Proteasome inhibitor sensitizes oral squamous cell carcinoma cells to TRAIL‑mediated apoptosis". Oncology Reports 49.5 (2023): 82.
Chicago
Yoshiba, S., Iwase, M., Kurihara, S., Uchida, M., Kurihara, Y., Watanabe, H., Shintani, S."[Retracted] Proteasome inhibitor sensitizes oral squamous cell carcinoma cells to TRAIL‑mediated apoptosis". Oncology Reports 49, no. 5 (2023): 82. https://doi.org/10.3892/or.2023.8519